臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"yu c c"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 211-235 / 665 (共27頁)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-02-02T05:45:08Z	Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection	Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; YI-CHIA LEE; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Wu M.-S.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏	2021-02-02T02:25:00Z	Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection	Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; MING-SHIANG WU; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; MING-SHIANG WU; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏	2021-02-02T02:21:36Z	VCP Phosphorylation-Dependent Interaction Partners Prevent Apoptosis in Helicobacter pylori-Infected Gastric Epithelial Cells	Yu C.-C.; Yang J.-C.; Chang Y.-C.; Chuang J.-G.; Lin C.-W.; MING-SHIANG WU; Chow L.-P.
臺大學術典藏	2021-02-02T02:21:36Z	Osteopontin promoter polymorphisms are associated with susceptibility to gastric cancer	Lee T.-Y.; Lin J.-T.; Wu C.-C.; Yu C.-C.; MING-SHIANG WU; Lee T.-C.; Chen H.-P.; Wu C.-Y.
臺大學術典藏	2021-02-02T02:20:53Z	Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection	Liou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; Fang Y.-J.; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; MING-SHIANG WU; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; MING-SHIANG WU; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏	2021-02-02T02:20:41Z	Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in Taiwan	Chen M.-J.; Fang Y.-J.; MING-SHIANG WU; Chen C.-C.; Chen Y.-N.; Yu C.-C.; Kuo C.-C.; Chiu M.-C.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen H.-H.; Bair M.-J.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium
臺大學術典藏	2021-02-02T02:20:39Z	Accuracy of rapid Helicobacter pylori antigen tests for the surveillance of the updated prevalence of H. pylori in Taiwan	Fang Y.-J.; Chen M.-J.; Chen C.-C.; Lee J.-Y.; Yang T.-H.; Yu C.-C.; Chiu M.-C.; Kuo C.-C.; Weng Y.-J.; Bair M.-J.; MING-SHIANG WU; Luo J.-C.; Liou J.-M.
臺大學術典藏	2021-02-02T00:46:59Z	Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy	Huang S.-P.;Huang C.-Y.;Wu W.-J.;Yeong-Shiau Pu;Chen J.;Chen Y.-Y.;Yu C.-C.;Wu T.T.;Wang J.-S.;Lee Y.-H.;Huang J.-K.;Huang C.-H.;Wu M.-T.; Huang S.-P.; Huang C.-Y.; Wu W.-J.; YEONG-SHIAU PU; Chen J.; Chen Y.-Y.; Yu C.-C.; Wu T.T.; Wang J.-S.; Lee Y.-H.; Huang J.-K.; Huang C.-H.; Wu M.-T.
臺大學術典藏	2021-02-02T00:46:55Z	Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post-radical prostatectomy	Huang S.-P.;Huang C.-Y.;Wang J.-S.;Liu C.-C.;Yeong-Shiau Pu;Yu H.-J.;Yu C.-C.;Wu T.T.;Huang C.-H.;Wu W.-J.;Chou Y.-H.;Wu M.-T.; Huang S.-P.; Huang C.-Y.; Wang J.-S.; Liu C.-C.; YEONG-SHIAU PU; Yu H.-J.; Yu C.-C.; Wu T.T.; Huang C.-H.; Wu W.-J.; Chou Y.-H.; Wu M.-T.
臺大學術典藏	2021-02-02T00:46:45Z	Clinical outcome of Taiwanese men with clinically localized prostate cancer post-radical prostatectomy: a comparison with other ethnic groups.	Huang S.P.;Huang C.Y.;Liu C.C.;Yu C.C.;Yeong-Shiau Pu;Chueh S.C.;Yu H.J.;Wu T.T.;Li C.C.;Huang C.H.;Wu W.J.; Huang S.P.; Huang C.Y.; Liu C.C.; Yu C.C.; YEONG-SHIAU PU; Chueh S.C.; Yu H.J.; Wu T.T.; Li C.C.; Huang C.H.; Wu W.J.
臺大學術典藏	2021-02-02T00:46:40Z	Impact of prostate-specific antigen (PSA) nadir and time to PSA nadir on disease progression in prostate cancer treated with androgen-deprivation therapy	Huang S.-P. ;Bao B.-Y. ;Wu M.-T. ;Choueiri T.K. ;Goggins W.B. ;Huang C.-Y. ;Yeong-Shiau Pu ;Yu C.-C. ;Huang C.-H.; Huang S.-P.; Bao B.-Y.; Wu M.-T.; Choueiri T.K.; Goggins W.B.; Huang C.-Y.; YEONG-SHIAU PU; Yu C.-C.; Huang C.-H.
臺大學術典藏	2021-02-02T00:46:38Z	Prognostic significance of genetic polymorphisms on prostate-specific antigen recurrence after a radical prostatectomy	Tsai Y.-F.; Bao B.-Y.; Liu C.-C.; Huang C.-N.; Yu C.-C.; Wu T.T.; Huang C.-Y.; YEONG-SHIAU PU; Chang C.-F.; Huang C.-H.; Wu W.-J.; Huang S.-P.
臺大學術典藏	2021-02-02T00:46:37Z	Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy	Huang S.-P.; Bao B.-Y.; Wu M.-T.; Choueiri T.K.; Goggins W.B.; Liu C.-C.; Huang C.-Y.; YEONG-SHIAU PU; Yu C.-C.; Wu T.T.; Huang C.-N.; Huang C.-H.; Wu W.-J.
臺大學術典藏	2021-02-02T00:46:33Z	Prognostic significance of cyclin d1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy	Yu C.-C.; Lin V.C.; Huang C.-Y.; Liu C.-C.; Wang J.-S.; Wu T.T.; YEONG-SHIAU PU; Huang C.-H.; Huang C.-N.; Huang S.-P.; Bao B.-Y.
臺大學術典藏	2021-02-02T00:43:34Z	Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post-radical prostatectomy	Huang S.-P.;Huang C.-Y.;Wang J.-S.;Liu C.-C.;Pu Y.-S.;Hong-Jeng Yu;Yu C.-C.;Wu T.T.;Huang C.-H.;Wu W.-J.;Chou Y.-H.;Wu M.-T.; Huang S.-P.; Huang C.-Y.; Wang J.-S.; Liu C.-C.; Pu Y.-S.; HONG-JENG YU; Yu C.-C.; Wu T.T.; Huang C.-H.; Wu W.-J.; Chou Y.-H.; Wu M.-T.
臺大學術典藏	2021-02-02T00:43:21Z	Clinical outcome of Taiwanese men with clinically localized prostate cancer post-radical prostatectomy: a comparison with other ethnic groups.	Huang S.P.;Huang C.Y.;Liu C.C.;Yu C.C.;Pu Y.S.;Chueh S.C.;Hong-Jeng Yu;Wu T.T.;Li C.C.;Huang C.H.;Wu W.J.; Huang S.P.; Huang C.Y.; Liu C.C.; Yu C.C.; Pu Y.S.; Chueh S.C.; HONG-JENG YU; Wu T.T.; Li C.C.; Huang C.H.; Wu W.J.
臺大學術典藏	2021-02-02T00:43:19Z	Reliability and validity of the Taiwan Chinese version of the EORTC QLQ-PR25 in assessing quality of life of prostate cancer patients	Chie W.-C.;Yu C.-C.;Hong-Jeng Yu; Chie W.-C.; Yu C.-C.; HONG-JENG YU
臺大學術典藏	2021-02-01T07:30:24Z	Risk of sepsis in patients with primary aldosteronism 11 Medical and Health Sciences 1103 Clinical Sciences	Chan C.-K.;Hu Y.-H.;Chen L.;Chang C.-C.;Lin Y.-F.;Lai T.-S.;Huang K.-H.;Lin Y.-H.;Wu V.-C.;Wu K.-D.;Lin J.-H.;Wang W.-J.;Wu C.-H.;Chang C.-H.;Chang Y.-L.;Tsai Y.-C.;Yu C.-C.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Shuo-Meng Wang;Liao S.-C.;Lu C.-C.;Yen R.-F.; Chan C.-K.; Hu Y.-H.; Chen L.; Chang C.-C.; Lin Y.-F.; Lai T.-S.; Huang K.-H.; Lin Y.-H.; Wu V.-C.; Wu K.-D.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Chang C.-H.; Chang Y.-L.; Tsai Y.-C.; Yu C.-C.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; SHUO-MENG WANG; Liao S.-C.; Lu C.-C.; Yen R.-F.
臺大學術典藏	2021-02-01T07:30:23Z	Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism	Huang K.-H.;Yu C.-C.;Hu Y.-H.;Chang C.-C.;Chan C.-K.;Liao S.-C.;Tsai Y.-C.;Jeff Chueh S.-C.;Wu V.-C.;Lin Y.-H.;Lin J.-H.;Wang W.-J.;Wu C.-H.;Er L.K.;Chang C.-H.;Chang Y.-L.;Ho Y.-L.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Liu K.-L.;Shuo-Meng Wang;Lu C.-C.;Yen R.-F.;Wu K.-D.;Taipai, Taiwan Primary Aldosteronism Investigator; Huang K.-H.; Yu C.-C.; Hu Y.-H.; Chang C.-C.; Chan C.-K.; Liao S.-C.; Tsai Y.-C.; Jeff Chueh S.-C.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; SHUO-MENG WANG; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator
臺大學術典藏	2021-01-29T03:17:21Z	A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase i	Yu C.-C.;Pan S.-L.;Chao S.-W.;Shih-Ping Liu;Hsu J.-L.;Yang Y.-C.;Li T.-K.;Huang W.-J.;Guh J.-H.; Yu C.-C.; Pan S.-L.; Chao S.-W.; SHIH-PING LIU; Hsu J.-L.; Yang Y.-C.; Li T.-K.; Huang W.-J.; Guh J.-H.
臺大學術典藏	2021-01-29T03:17:19Z	KUD773, a phenylthiazole derivative, displays anticancer activity in human hormone-refractory prostate cancers through inhibition of tubulin polymerization and anti-Aurora a activity	Yu C.-C.;Shih-Ping Liu;Hsu J.-L.;Hsu J.T.A.;Kudryavtsev K.;Guh J.-H.; Yu C.-C.; SHIH-PING LIU; Hsu J.-L.; Hsu J.T.A.; Kudryavtsev K.; Guh J.-H.
臺大學術典藏	2021-01-29T03:17:17Z	Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: The role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways	Leu W.-J.; Swain S.P.; Chan S.-H.; Hsu J.-L.; SHIH-PING LIU; Chan M.-L.; Yu C.-C.; Hsu L.-C.; Chou Y.-L.; Chang W.-L.; Hou D.-R.; Guh J.-H.
臺大學術典藏	2021-01-29T03:17:15Z	Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways	Chan M.-L.;Yu C.-C.;Hsu J.-L.;Leu W.-J.;Chan S.-H.;Hsu L.-C.;Shih-Ping Liu;Ivantcova P.M.;Dogan ?.;Br?Se S.;Kudryavtsev K.V.;Guh J.-H.; Chan M.-L.; Yu C.-C.; Hsu J.-L.; Leu W.-J.; Chan S.-H.; Hsu L.-C.; SHIH-PING LIU; Ivantcova P.M.; Dogan ?.; Br?se S.; Kudryavtsev K.V.; Guh J.-H.
臺大學術典藏	2021-01-29T03:17:13Z	Phosphodiesterase type 5 (PDE5) inhibitors sensitize topoisomerase II inhibitors in killing prostate cancer through PDE5-independent impairment of HR and NHEJ DNA repair systems	Chang J.-F.;Hsu J.-L.;Sheng Y.-H.;Leu W.-J.;Yu C.-C.;Chan S.-H.;Chan M.-L.;Hsu L.-C.;Shih-Ping Liu;Guh J.-H.; Chang J.-F.; Hsu J.-L.; Sheng Y.-H.; Leu W.-J.; Yu C.-C.; Chan S.-H.; Chan M.-L.; Hsu L.-C.; SHIH-PING LIU; Guh J.-H.
臺大學術典藏	2021-01-28T02:02:49Z	Risk of sepsis in patients with primary aldosteronism 11 Medical and Health Sciences 1103 Clinical Sciences	Chan C.-K.;Hu Y.-H.;Chen L.;Chang C.-C.;Lin Y.-F.;Lai T.-S.;Kuo-How Huang;Lin Y.-H.;Wu V.-C.;Wu K.-D.;Lin J.-H.;Wang W.-J.;Wu C.-H.;Chang C.-H.;Chang Y.-L.;Tsai Y.-C.;Yu C.-C.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Wang S.-M.;Liao S.-C.;Lu C.-C.;Yen R.-F.; Chan C.-K.; Hu Y.-H.; Chen L.; Chang C.-C.; Lin Y.-F.; Lai T.-S.; KUO-HOW HUANG; Lin Y.-H.; Wu V.-C.; Wu K.-D.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Chang C.-H.; Chang Y.-L.; Tsai Y.-C.; Yu C.-C.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Wang S.-M.; Liao S.-C.; Lu C.-C.; Yen R.-F.

顯示項目 211-235 / 665 (共27頁)
<< < 4 5 6 7 8 9 10 11 12 13 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2856655
	造訪人次 : 53559207 線上人數 : 1025 教育部委託研究計畫計畫執行:國立臺灣大學圖書館